Cetuximab induced pro-inflammatory cytokine secretion from HNSCC cells in vitro which was mediated by an IL-1α/IL-1R1/MyD88-dependent signaling pathway. This evidence concerns the gene IL1R1 and head and neck squamous cell carcinoma.